Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income: 2019-2025

Historic Non Operating Income for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$1.7 million.

  • Biodesix's Non Operating Income rose 0.12% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 23.29%. This contributed to the annual value of -$8.4 million for FY2024, which is 21.95% up from last year.
  • As of Q3 2025, Biodesix's Non Operating Income stood at -$1.7 million, which was up 4.80% from -$1.7 million recorded in Q2 2025.
  • Biodesix's 5-year Non Operating Income high stood at $1.6 million for Q3 2021, and its period low was -$6.4 million during Q4 2022.
  • Moreover, its 3-year median value for Non Operating Income was -$2.3 million (2023), whereas its average is -$2.2 million.
  • In the last 5 years, Biodesix's Non Operating Income skyrocketed by 160.54% in 2021 and then tumbled by 415.09% in 2022.
  • Biodesix's Non Operating Income (Quarterly) stood at -$1.6 million in 2021, then plummeted by 302.25% to -$6.4 million in 2022, then spiked by 64.81% to -$2.3 million in 2023, then rose by 29.40% to -$1.6 million in 2024, then increased by 0.12% to -$1.7 million in 2025.
  • Its Non Operating Income was -$1.7 million in Q3 2025, compared to -$1.7 million in Q2 2025 and -$2.0 million in Q1 2025.